1665-5044 1665-5044 S1665-50442019000200069 10.24875/rmn.m19000058 México México México México México México México México 00 04 2019 00 04 2019 20 2 69 74

1 Practice parameter:a guideline for discontinuing antiepileptic drugs in seizure-free patients summary statement 1996 47 600-2 2 National Institute for Health and Clinical Excellence. NICE Clinical Guideline 137 2012 3 Guías diagnósticas y terapéuticas de la Sociedad Española de Neurología 2012 2012 4 2009 18 251-6 5 1994 35 534-45 6 1994 44 601-8 7 2008 49 Suppl 9 Suppl 9 25-8 8 2013 54 Suppl 7 Suppl 7 2-12 9 2017 16 523-31 10 2001 3 11 2001 16 874-81 12 1998 50 724-30 13 2009 73 1041-5 14 2012 53 1379-86 15 2002 72 22-5 16 2010 12 434-42 17 2017 12 18 2017 58 1524-32 19 2014 9 100-4 20 2018 31 211-5 21 2008 49 455-63 22 2015 17 211-28 23 2017 128 297-302 24 2011 52 627-35 25 2007 10 219-22 26 2004 127 2018-30 27 2009 15 476-80 28 2012 79 770-6 29 2010 51 181-9 30 Prognostic index for recurrence of seizures after remission of epilepsy 1993 306 1374-8 31 1992 33 681-6 32 1996 46 969-74 33 2011 20 520-5 34 2006 129 1269-80 35 1994 330 1407-10 36 2005 20 624-6 37 2011 82 1328-33 38 1995 4 19-36 39 1996 47 76-8